Wolfson Molecular Imaging Centre
The Wolfson Molecular Imaging Centre (WMIC) is a clinical and science led experimental medicine institute that uses Positron Emission Tomography (PET) molecular imaging. The WMIC aims to advance the understanding and treatment of cancer and brain disorders through research studies and clinical trials performed under strict governance procedures.
Founded on an academically driven and interdisciplinary approach, WMIC provides a means of bridging the gap between laboratory science and clinical areas. The centre has a research focus on oncology, neurology and psychiatry with full access to national UK clinical research networks.
The Centre is located at one of Europe's biggest cancer treatment hospitals, the Christie Hospital in Manchester. WMIC is housed in a building that has been purposely designed and built to meet all the needs of PET based molecular imaging. Patients and healthy volunteers take part in ground breaking research studies in collaboration with the Christie Hospital, the three main University Hospitals: Hope, Manchester Royal Infirmary and Wythenshawe and other hospitals throughout the UK.
By supporting interdisciplinary and collaborative working, PET research can support the early stages of development for the measurement of in-vivo expression of targets in disease and health. The research also provides a mechanism of action studies of novel therapies and pharmacokinetic/pharmacodynamic response to novel agents, together with biological efficacy of novel therapies.
Further information
For more details, see: Imaging Facilities
Related people
- Alan Jackson (Director)
